4.5 Article

Age-dependent reference intervals in children for the disialoganglioside, GD2, a circulating tumor biomarker for the childhood cancer, neuroblastoma

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Revised Neuroblastoma Risk Classification System: A Report From the Children's Oncology Group

Meredith S. Irwin et al.

Summary: A revised neuroblastoma risk classifier incorporating INRGSS and SCAs has been validated, which may impact clinical trial eligibility and treatment assignment.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Article Oncology

The ganglioside GD2 as a circulating tumor biomarker for neuroblastoma

Frank Milton Balis et al.

PEDIATRIC BLOOD & CANCER (2020)

Article Biochemical Research Methods

A validated HPLC-MS/MS method for estimating the concentration of the ganglioside, G(D2), in human plasma or serum

C. M. Busch et al.

JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2018)

Review Biochemistry & Molecular Biology

Gangliosides: glycosphingolipids essential for normal neural development and function

Cara-Lynne Schengrund

TRENDS IN BIOCHEMICAL SCIENCES (2015)

Review Cell Biology

Death of developing neurons: New insights and implications for connectivity

Martijn P. J. Dekkers et al.

JOURNAL OF CELL BIOLOGY (2013)

Article Medicine, General & Internal

Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma.

Alice L. Yu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)